Last update :
26/05/2020
References   References 4355  
Type : Manufacturer

Research teams :
Authors :
Title : Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics
Reference : Jazz Pharmaceuticals UK 2019

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionDaunorubicin/cytarabine liposomale Anticancer drug
Stability in solutions Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
Stability in solutions Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
Stability in solutions Polyolefine NaCl 0,9% or Glucose 5% 0.087 / 0.195 mg/mL 2-8°C Not specified
4 Hour
Stability in solutions Polyolefine NaCl 0,9% or Glucose 5% 0.176 / 0.4 mg/mL 2-8°C Not specified
4 Hour

  Mentions Légales